Table 2.
Family | Race | Country | Gene | Protein change | Inheritance | Age at onset (yr) | Renal biopsy | Diagnosis |
---|---|---|---|---|---|---|---|---|
6,511 | White | USA | WT1 | p.T416A | AD | 31–35 | FSGS | SRNS |
6,586 | White | USA | WT1 | p.C393Y | AD | 46–50 | FSGS | SRNS |
6,725 | White | USA | NPHS2 | p.Y162X | Sporadic | 1–5 | FSGS | SRNS |
34,262 | White | USA | ACTN4 | p.D874N | Sporadic | 6–10 | FSGS | SRNS |
34,462 | Black | USA | INF2 | p.E249X | AD | 6–10 | FSGS | SRNS |
40,015 | Hispanic | USA | TRPC6 | p.G39fsX41 | Sporadic | 6–10 | MCD | SRNS |
AD, autosomal dominant; FSGS, focal segmental glomerulosclerosis; MCD, minimal change disease; SRNS, steroid-resistant nephrotic syndrome.